KURA ONCOLOGY, INC. General and Administrative Expense
KURA ONCOLOGY, INC. (KURA) reported General and Administrative Expense of $32.84 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2025-11-04
- KURA ONCOLOGY, INC. general and administrative expense for the quarter ending 2025-09-30 was $32.84M, a 80.64% increase year-over-year.
- KURA ONCOLOGY, INC. general and administrative expense for the quarter ending 2025-06-30 was $25.17M, a 50.92% increase year-over-year.
- KURA ONCOLOGY, INC. general and administrative expense for the quarter ending 2025-03-31 was $22.84M, a 25.58% increase year-over-year.
- KURA ONCOLOGY, INC. general and administrative expense for the quarter ending 2024-12-31 was $24.07M, a 69.17% increase year-over-year.
- KURA ONCOLOGY, INC. general and administrative expense for fiscal 2024 was $77.11M, a 52.49% increase from fiscal 2023.
- KURA ONCOLOGY, INC. general and administrative expense for fiscal 2023 was $50.57M, a 7.47% increase from fiscal 2022.
- KURA ONCOLOGY, INC. general and administrative expense for fiscal 2022 was $47.05M, a 1.11% increase from fiscal 2021.
- KURA ONCOLOGY, INC. general and administrative expense for fiscal 2021 was $46.54M, a 47.73% increase from fiscal 2020.
| Period end | General and Administrative Expense 1 month | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month | General and Administrative Expense 43 month | General and Administrative Expense 46 month | General and Administrative Expense 49 month | General and Administrative Expense 52 month | General and Administrative Expense 55 month | General and Administrative Expense 58 month | General and Administrative Expense 62 month | General and Administrative Expense 64 month | General and Administrative Expense 67 month | General and Administrative Expense 70 month | General and Administrative Expense 73 month | General and Administrative Expense 76 month | General and Administrative Expense 79 month | General and Administrative Expense 82 month | General and Administrative Expense 85 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $32.84M 10-Q · filed 2025-11-04 | $58.01M derived: sum of 2 quarters · filed 2025-11-04 | $80.84M 10-Q · filed 2025-11-04 | $104.91M derived: sum of 4 quarters · filed 2025-11-04 | ||||||||||||||||
| 2025-06-30 | $25.17M 10-Q · filed 2025-08-07 | $48.00M 10-Q · filed 2025-08-07 | $72.08M derived: sum of 3 quarters · filed 2025-08-07 | $90.25M derived: sum of 4 quarters · filed 2025-11-04 | ||||||||||||||||
| 2025-03-31 | $22.84M 10-Q · filed 2025-05-01 | $46.91M derived: sum of 2 quarters · filed 2025-05-01 | $65.08M derived: sum of 3 quarters · filed 2025-11-04 | $81.76M derived: sum of 4 quarters · filed 2025-11-04 | ||||||||||||||||
| 2024-12-31 | $24.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $42.25M derived: sum of 2 quarters · filed 2025-11-04 | $58.93M derived: sum of 3 quarters · filed 2025-11-04 | $77.11M 10-K · filed 2025-02-28 | ||||||||||||||||
| 2024-09-30 | $18.18M 10-Q · filed 2025-11-04 | $34.86M derived: sum of 2 quarters · filed 2025-11-04 | $53.04M 10-Q · filed 2025-11-04 | $67.27M derived: sum of 4 quarters · filed 2025-11-04 | ||||||||||||||||
| 2024-06-30 | $16.68M 10-Q · filed 2025-08-07 | $34.86M 10-Q · filed 2025-08-07 | $49.09M derived: sum of 3 quarters · filed 2025-08-07 | $62.23M derived: sum of 4 quarters · filed 2025-08-07 | ||||||||||||||||
| 2024-03-31 | $18.18M 10-Q · filed 2025-05-01 | $32.41M derived: sum of 2 quarters · filed 2025-05-01 | $45.56M derived: sum of 3 quarters · filed 2025-05-01 | $57.38M derived: sum of 4 quarters · filed 2025-05-01 | ||||||||||||||||
| 2023-12-31 | $14.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $27.37M derived: sum of 2 quarters · filed 2025-02-28 | $39.20M derived: sum of 3 quarters · filed 2025-02-28 | $50.57M 10-K · filed 2025-02-28 | ||||||||||||||||
| 2023-09-30 | $13.14M 10-Q · filed 2024-11-07 | $24.97M derived: sum of 2 quarters · filed 2024-11-07 | $36.34M 10-Q · filed 2024-11-07 | $48.83M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||||||
| 2023-06-30 | $11.82M 10-Q · filed 2024-08-08 | $23.20M 10-Q · filed 2024-08-08 | $35.68M derived: sum of 3 quarters · filed 2025-02-28 | $47.30M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||||||
| 2023-03-31 | $11.37M 10-Q · filed 2024-05-02 | $23.86M derived: sum of 2 quarters · filed 2025-02-28 | $35.48M derived: sum of 3 quarters · filed 2025-02-28 | $46.56M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||||||
| 2022-12-31 | $12.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $24.11M derived: sum of 2 quarters · filed 2025-02-28 | $35.18M derived: sum of 3 quarters · filed 2025-02-28 | $47.05M 10-K · filed 2025-02-28 | ||||||||||||||||
| 2022-09-30 | $11.62M 10-Q · filed 2023-11-02 | $22.70M derived: sum of 2 quarters · filed 2023-11-02 | $34.56M 10-Q · filed 2023-11-02 | $46.65M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||||
| 2022-06-30 | $11.07M 10-Q · filed 2023-08-09 | $22.94M 10-Q · filed 2023-08-09 | $35.03M derived: sum of 3 quarters · filed 2024-02-27 | $46.34M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||||
| 2022-03-31 | $11.87M 10-Q · filed 2023-05-10 | $23.95M derived: sum of 2 quarters · filed 2024-02-27 | $35.26M derived: sum of 3 quarters · filed 2024-02-27 | $47.83M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||||
| 2021-12-31 | $12.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $23.39M derived: sum of 2 quarters · filed 2024-02-27 | $35.97M derived: sum of 3 quarters · filed 2024-02-27 | $46.54M 10-K · filed 2024-02-27 | ||||||||||||||||
| 2021-09-30 | $11.31M 10-Q · filed 2022-11-03 | $23.88M derived: sum of 2 quarters · filed 2022-11-03 | $34.45M 10-Q · filed 2022-11-03 | $43.26M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||||
| 2021-06-30 | $12.57M 10-Q · filed 2022-08-03 | $23.14M 10-Q · filed 2022-08-03 | $31.95M derived: sum of 3 quarters · filed 2023-02-23 | $39.55M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||||
| 2021-03-31 | $10.57M 10-Q · filed 2022-05-04 | $19.38M derived: sum of 2 quarters · filed 2023-02-23 | $26.97M derived: sum of 3 quarters · filed 2023-02-23 | $34.45M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||||
| 2020-12-31 | $8.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $16.40M derived: sum of 2 quarters · filed 2023-02-23 | $23.88M derived: sum of 3 quarters · filed 2023-02-23 | $31.50M 10-K · filed 2023-02-23 | ||||||||||||||||
| 2020-09-30 | $7.59M 10-Q · filed 2021-11-04 | $15.07M derived: sum of 2 quarters · filed 2021-11-04 | $22.69M 10-Q · filed 2021-11-04 | $28.19M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||||||
| 2020-06-30 | $7.48M 10-Q · filed 2021-08-05 | $15.10M 10-Q · filed 2021-08-05 | $20.60M derived: sum of 3 quarters · filed 2022-02-24 | $25.73M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||||||
| 2020-03-31 | $7.63M 10-Q · filed 2021-05-06 | $13.12M derived: sum of 2 quarters · filed 2022-02-24 | $18.26M derived: sum of 3 quarters · filed 2022-02-24 | $22.71M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||||||
| 2019-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $10.63M derived: sum of 2 quarters · filed 2022-02-24 | $15.08M derived: sum of 3 quarters · filed 2022-02-24 | $19.65M 10-K · filed 2022-02-24 | ||||||||||||||||
| 2019-09-30 | $5.13M 10-Q · filed 2020-11-05 | $9.59M derived: sum of 2 quarters · filed 2020-11-05 | $14.15M 10-Q · filed 2020-11-05 | |||||||||||||||||
| 2019-06-30 | $4.45M 10-Q · filed 2020-08-06 | $9.02M 10-Q · filed 2020-08-06 | ||||||||||||||||||
| 2019-03-31 | $4.57M 10-Q · filed 2020-05-04 | |||||||||||||||||||
| 2018-12-31 | $16.10M 10-K · filed 2021-02-24 | |||||||||||||||||||
| 2017-12-31 | $9.65M 10-K · filed 2020-02-25 | |||||||||||||||||||
| 2015-09-30 | $1.78M 10-Q · filed 2015-11-13 | $3.27M derived: sum of 2 quarters · filed 2015-11-13 | $4.31M 10-Q · filed 2015-11-13 | $4.32M derived: sum of 4 quarters · filed 2015-11-13 | ||||||||||||||||
| 2015-06-30 | $1.49M 10-Q · filed 2015-08-14 | $2.53M 10-Q · filed 2015-08-14 | $2.54M derived: sum of 3 quarters · filed 2015-08-14 | $2.54M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2015-03-31 | $1.04M 10-Q · filed 2015-05-13 | $1.05M derived: sum of 2 quarters · filed 2015-05-13 | $1.05M derived: sum of 3 quarters · filed 2015-05-13 | $1.06M derived: sum of 4 quarters · filed 2015-05-13 | ||||||||||||||||
| 2014-12-31 | $9.76K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $14.53K derived: sum of 2 quarters · filed 2015-02-27 | $19.77K derived: sum of 3 quarters · filed 2015-02-27 | $23.91K 10-K · filed 2015-02-27 | $165.05K 10-K · filed 2015-02-27 | |||||||||||||||
| 2014-09-30 | $63.00K 10-Q · filed 2015-11-13 | $4.76K 10-Q · filed 2014-11-14 | $10.01K derived: sum of 2 quarters · filed 2014-11-14 | $14.14K 10-Q · filed 2014-11-14 | $22.23K derived: sum of 4 quarters · filed 2015-02-27 | $155.28K 10-Q · filed 2014-11-14 | ||||||||||||||
| 2014-06-30 | $5.24K 10-Q · filed 2014-08-14 | $9.38K 10-Q · filed 2014-08-14 | $17.47K derived: sum of 3 quarters · filed 2015-02-27 | $21.94K derived: sum of 4 quarters · filed 2015-02-27 | $150.52K 10-Q · filed 2014-08-14 | |||||||||||||||
| 2014-03-31 | $4.14K 10-Q · filed 2014-05-15 | $12.22K derived: sum of 2 quarters · filed 2015-02-27 | $16.70K derived: sum of 3 quarters · filed 2015-02-27 | $22.16K derived: sum of 4 quarters · filed 2015-02-27 | $145.28K 10-Q · filed 2014-05-15 | |||||||||||||||
| 2013-12-31 | $8.09K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $12.56K derived: sum of 2 quarters · filed 2015-02-27 | $18.02K derived: sum of 3 quarters · filed 2015-02-27 | $22.73K 10-K · filed 2015-02-27 | $141.14K 10-K · filed 2014-03-31 | |||||||||||||||
| 2013-09-30 | $4.47K 10-Q · filed 2014-11-14 | $9.93K derived: sum of 2 quarters · filed 2014-11-14 | $14.65K 10-Q · filed 2014-11-14 | $23.02K derived: sum of 4 quarters · filed 2014-11-14 | $133.05K 10-Q · filed 2013-11-14 | |||||||||||||||
| 2013-06-30 | $5.46K 10-Q · filed 2014-08-14 | $10.17K 10-Q · filed 2014-08-14 | $18.55K derived: sum of 3 quarters · filed 2014-08-14 | $23.28K derived: sum of 4 quarters · filed 2014-08-14 | $128.58K 10-Q · filed 2013-08-14 | |||||||||||||||
| 2013-03-31 | $4.72K 10-Q · filed 2014-05-15 | $13.09K derived: sum of 2 quarters · filed 2014-05-15 | $17.82K derived: sum of 3 quarters · filed 2014-05-15 | $22.82K derived: sum of 4 quarters · filed 2014-05-15 | $123.12K 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | $8.38K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $13.10K derived: sum of 2 quarters · filed 2014-03-31 | $18.10K derived: sum of 3 quarters · filed 2014-03-31 | $22.34K 10-K · filed 2014-03-31 | $118.41K 10-K · filed 2013-03-28 | |||||||||||||||
| 2012-09-30 | $4.73K 10-Q · filed 2013-11-14 | $9.72K derived: sum of 2 quarters · filed 2013-11-14 | $13.96K 10-Q · filed 2013-11-14 | $21.94K derived: sum of 4 quarters · filed 2013-11-14 | $110.03K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | $5.00K 10-Q · filed 2013-08-14 | $9.24K 10-Q · filed 2013-08-14 | $17.21K derived: sum of 3 quarters · filed 2013-08-14 | $22.57K derived: sum of 4 quarters · filed 2013-08-14 | $105.30K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2012-03-31 | $4.24K 10-Q · filed 2013-05-15 | $12.22K derived: sum of 2 quarters · filed 2013-05-15 | $17.58K derived: sum of 3 quarters · filed 2013-05-15 | $23.41K derived: sum of 4 quarters · filed 2013-05-15 | $100.31K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $7.98K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $13.34K derived: sum of 2 quarters · filed 2013-03-28 | $19.17K derived: sum of 3 quarters · filed 2013-03-28 | $23.44K 10-K · filed 2013-03-28 | $96.06K 10-K · filed 2012-03-30 | |||||||||||||||
| 2011-09-30 | $5.36K 10-Q · filed 2012-11-14 | $11.20K derived: sum of 2 quarters · filed 2012-11-14 | $15.46K 10-Q · filed 2012-11-14 | $22.68K derived: sum of 4 quarters · filed 2012-11-14 | $88.09K 10-Q · filed 2011-11-14 | |||||||||||||||
| 2011-06-30 | $5.84K 10-Q · filed 2012-08-14 | $10.10K 10-Q · filed 2012-08-14 | $17.32K derived: sum of 3 quarters · filed 2012-08-14 | $21.55K derived: sum of 4 quarters · filed 2012-08-14 | $82.73K 10-Q · filed 2011-08-15 | |||||||||||||||
| 2011-03-31 | $4.27K 10-Q · filed 2012-05-15 | $11.48K derived: sum of 2 quarters · filed 2012-05-15 | $15.72K derived: sum of 3 quarters · filed 2012-05-15 | $20.84K derived: sum of 4 quarters · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $7.21K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $11.45K derived: sum of 2 quarters · filed 2012-03-30 | $16.57K derived: sum of 3 quarters · filed 2012-03-30 | $20.51K 10-K · filed 2012-03-30 | ||||||||||||||||
| 2010-09-30 | $4.24K 10-Q · filed 2011-11-14 | $9.36K derived: sum of 2 quarters · filed 2011-11-14 | $13.29K 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2010-06-30 | $5.12K 10-Q · filed 2011-08-15 | $9.06K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |